Tesamorelin advantages :There are GH and IGF-1, why needs Tesamorelin peptides ?
The benefits of Tesamorelin
Tesamorelin plays a similar role to GHRH by binding to GHRH receptors, stimulating the synthesis and release of endogenous GH. The released GH boosts metabolism and improves muscle growth, helping to burn more calories and reduce fat in the body. Tesamorelin also helps to increase IGF-1 levels, which further enhances metabolic levels and stimulates lipolysis. Especially for parts such as the abdomen where fat is easy to accumulate and difficult to remove, the use of Tesamorelin is better.
In the Tesamorelin trial, after 3 to 12 months of treatment, the subjects' organ fat was reduced by 10 to 20 percent, and the average visceral fat was reduced by 18 percent.
Various experiments targeting Tesamorelin also showed that Tesamorelin treatment reduced fat mass while increasing lean muscle mass. Through changes in trunk muscles based on computed tomography (CT), it was found that compared with the placebo group, all trunk muscle groups of the subjects, Including rectus abdominis, anterolateral abdominis, psoas major and paravertebral muscles, total muscle density and area increased significantly.
Tesamorelin vs HGH
Tesamorelin acts on the front end of HGH, and although it also acts by stimulating the production and release of GH, it has two main advantages over the direct use of HGH.
One is that Tesamorelin is used in the process of reducing abdominal fat, which does not stimulate excessive GH secretion. So it does not bring the side effects of HGH excess.
Second, the direct use of HGH treatment can cause slight impairment of glucose metabolism in patients in a short period of time, while the use of Tesamorelin treatment can significantly reduce the amount of fat in obese individuals without affecting glucose metabolism.
Tesamorelin plays a similar role to GHRH by binding to GHRH receptors, stimulating the synthesis and release of endogenous GH. The released GH boosts metabolism and improves muscle growth, helping to burn more calories and reduce fat in the body. Tesamorelin also helps to increase IGF-1 levels, which further enhances metabolic levels and stimulates lipolysis. Especially for parts such as the abdomen where fat is easy to accumulate and difficult to remove, the use of Tesamorelin is better.
In the Tesamorelin trial, after 3 to 12 months of treatment, the subjects' organ fat was reduced by 10 to 20 percent, and the average visceral fat was reduced by 18 percent.
Various experiments targeting Tesamorelin also showed that Tesamorelin treatment reduced fat mass while increasing lean muscle mass. Through changes in trunk muscles based on computed tomography (CT), it was found that compared with the placebo group, all trunk muscle groups of the subjects, Including rectus abdominis, anterolateral abdominis, psoas major and paravertebral muscles, total muscle density and area increased significantly.
Tesamorelin vs HGH
Tesamorelin acts on the front end of HGH, and although it also acts by stimulating the production and release of GH, it has two main advantages over the direct use of HGH.
One is that Tesamorelin is used in the process of reducing abdominal fat, which does not stimulate excessive GH secretion. So it does not bring the side effects of HGH excess.
Second, the direct use of HGH treatment can cause slight impairment of glucose metabolism in patients in a short period of time, while the use of Tesamorelin treatment can significantly reduce the amount of fat in obese individuals without affecting glucose metabolism.